CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale EVP, CBO, GC & Secretary sold 26,500 shares at an average $25.37 ($672,279)
- 4 Open-market sale Director sold 5,000 shares at $23.50 ($117,500)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Chief Medical Officer sold 1,375 shares at $16.48 ($22,663)
- 4 Open-market sale Chief Dev Operations Officer sold 2,975 shares at $16.48 ($49,034)
- 4 Open-market sale EVP, CBO, GC & Secretary sold 2,961 shares at $16.48 ($48,803)
- 4 Open-market sale President & CSO sold 17,634 shares at $16.48 ($290,642)
- 4 Open-market sale Chief Executive Officer sold 17,634 shares at $16.48 ($290,642)
- 4 Exercise or conversion EVP, Chief Medical Officer acquired 4,850 shares (option exercise)
- 4 Exercise or conversion Chief Dev Operations Officer acquired 9,675 shares (option exercise)
- 4 Exercise or conversion EVP, CBO, GC & Secretary acquired 9,675 shares (option exercise)
- 4 Exercise or conversion President & CSO acquired 43,600 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 43,600 shares (option exercise)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 31 · 601 filings